PL2007347T3 - Kompozycja obejmująca środek do stabilizowania substancji czynnych w wodzie do picia i mieszankę musującą, sposób jej wytwarzania i jej zastosowanie - Google Patents
Kompozycja obejmująca środek do stabilizowania substancji czynnych w wodzie do picia i mieszankę musującą, sposób jej wytwarzania i jej zastosowanieInfo
- Publication number
- PL2007347T3 PL2007347T3 PL07711695T PL07711695T PL2007347T3 PL 2007347 T3 PL2007347 T3 PL 2007347T3 PL 07711695 T PL07711695 T PL 07711695T PL 07711695 T PL07711695 T PL 07711695T PL 2007347 T3 PL2007347 T3 PL 2007347T3
- Authority
- PL
- Poland
- Prior art keywords
- agent
- composition
- production
- drinking water
- active substances
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/68—Treatment of water, waste water, or sewage by addition of specified substances, e.g. trace elements, for ameliorating potable water
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/02—Non-contaminated water, e.g. for industrial water supply
- C02F2103/026—Treating water for medical or cosmetic purposes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Hydrology & Water Resources (AREA)
- Environmental & Geological Engineering (AREA)
- Water Supply & Treatment (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006009338 | 2006-02-28 | ||
DE102006023578 | 2006-05-19 | ||
DE102006054260A DE102006054260A1 (de) | 2006-02-28 | 2006-11-17 | Wasser stabilisierende Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung |
PCT/EP2007/001679 WO2007098924A2 (de) | 2006-02-28 | 2007-02-27 | Zusammensetzung umfassend ein mittel zum stabilisieren von wirkstoffen im trinkwasser und eine brausemischung, verfahren zu deren herstellung und deren verwendung |
EP07711695.2A EP2007347B1 (de) | 2006-02-28 | 2007-02-27 | Zusammensetzung umfassend ein mittel zum stabilisieren von wirkstoffen im trinkwasser und eine brausemischung, verfahren zu deren herstellung und deren verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2007347T3 true PL2007347T3 (pl) | 2019-04-30 |
Family
ID=38434716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07711695T PL2007347T3 (pl) | 2006-02-28 | 2007-02-27 | Kompozycja obejmująca środek do stabilizowania substancji czynnych w wodzie do picia i mieszankę musującą, sposób jej wytwarzania i jej zastosowanie |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2007347B1 (pl) |
JP (1) | JP5305199B2 (pl) |
DE (1) | DE102006054260A1 (pl) |
ES (1) | ES2709634T3 (pl) |
PL (1) | PL2007347T3 (pl) |
PT (1) | PT2007347T (pl) |
WO (1) | WO2007098924A2 (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8631487B2 (en) | 2010-12-16 | 2014-01-14 | Research In Motion Limited | Simple algebraic and multi-layer passwords |
EP2945650B1 (en) * | 2012-04-23 | 2023-07-05 | Bharat Biotech International Limited | Rotavirus vaccine compositions and process for preparing the same |
US20170252295A1 (en) | 2014-09-17 | 2017-09-07 | Steerlife India Private Limited | Effervescent composition and method of making it |
WO2017098481A1 (en) | 2015-12-12 | 2017-06-15 | Steerlife India Private Limited | Effervescent compositions of metformin and processes for preparation thereof |
FR3070684B1 (fr) * | 2017-09-04 | 2020-05-22 | Nor-Feed | Procede de distribution d'un produit de traitement, par l'intermediaire d'une eau d'abreuvement |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1165098A (en) * | 1968-03-25 | 1969-09-24 | H & T Kirby & Company Ltd | Improvements in the Preparation of Chlorine-Producing Bactericidal Compositions |
GB1221038A (en) * | 1969-09-18 | 1971-02-03 | H & T Kirby & Company Ltd | Improvements in effervescent tablet compositions |
DE3933164B4 (de) * | 1988-10-04 | 2005-08-18 | Otsuka Pharmaceutical Co., Ltd. | Mittel für eine Eisenzufuhr |
ES2060736T3 (es) * | 1989-01-12 | 1994-12-01 | Bayer Ag | Composicion antiacida analgesica efervescente con un contenido en sodio reducido. |
DE59003811D1 (de) * | 1989-09-07 | 1994-01-20 | Thomas Gergely | Magensäure bindende, pharmazeutische zubereitung. |
JPH0556231U (ja) * | 1992-01-07 | 1993-07-27 | 雪印乳業株式会社 | 粉体の溶解装置 |
DE69726879T2 (de) * | 1996-05-17 | 2004-10-14 | Merck & Co., Inc. | Biphosphonat-formulierung mit brausewirkung |
DE19700368A1 (de) * | 1996-07-16 | 1998-07-09 | Lydia Dr Ing Jakubowicz | Verfahren zur Herstellung von allgemein zugänglichen stabile Fe·2··+·-Kationen enthaltenden wäßrigen Getränken |
AT407008B (de) * | 1998-08-06 | 2000-11-27 | Viernstein Helmut Dr | Formulierungen mit probiotisch wirksamen mikroorganismen |
FR2793685B1 (fr) * | 1999-05-19 | 2001-08-24 | Promindus Actions Promotionnel | Compositions pharmaceutiques, destinees a l'administration par voie orale de phloroglucinol et leur preparation |
CA2382652A1 (en) * | 1999-08-24 | 2001-03-01 | Teva Pharmaceutical Industries, Ltd. | A vaccine composition and method of using the same |
US6592869B2 (en) * | 1999-08-24 | 2003-07-15 | Teva Pharmaceutical Industries, Ltd. | Vaccine composition and method of using the same |
US6485940B2 (en) * | 2000-07-07 | 2002-11-26 | Akzo Nobel N.V. | Broad spectrum infectious bursal disease virus vaccine |
-
2006
- 2006-11-17 DE DE102006054260A patent/DE102006054260A1/de not_active Withdrawn
-
2007
- 2007-02-27 PL PL07711695T patent/PL2007347T3/pl unknown
- 2007-02-27 EP EP07711695.2A patent/EP2007347B1/de active Active
- 2007-02-27 PT PT07711695T patent/PT2007347T/pt unknown
- 2007-02-27 JP JP2008556706A patent/JP5305199B2/ja active Active
- 2007-02-27 ES ES07711695T patent/ES2709634T3/es active Active
- 2007-02-27 WO PCT/EP2007/001679 patent/WO2007098924A2/de active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP2007347A2 (de) | 2008-12-31 |
JP5305199B2 (ja) | 2013-10-02 |
EP2007347B1 (de) | 2018-11-28 |
DE102006054260A1 (de) | 2007-09-27 |
JP2009528311A (ja) | 2009-08-06 |
WO2007098924A3 (de) | 2007-12-13 |
WO2007098924A2 (de) | 2007-09-07 |
PT2007347T (pt) | 2019-02-04 |
ES2709634T3 (es) | 2019-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2434604B (en) | Porous composites containing hydrocarbon-soluble well treatment agents and methods for using the same | |
TWI347215B (en) | Water dispersion liquid and method for producing the same, and composition, binding agent and coating agent | |
IL192053A (en) | 2-Admentiluria derivatives as selective inhibitors of 1hsd-β11 and their use in drug preparation | |
EP2098222A4 (en) | GRANULAR COMPOSITION CONTAINING PHYSIOLOGICALLY ACTIVE SUBSTANCE AND METHOD FOR PRODUCING THE SAME | |
PT2044076E (pt) | Processo de preparação de asenapina e de produtos intermediários utilizados no referido processo | |
IL177717A0 (en) | Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders | |
PL1776010T3 (pl) | Sposób wytwarzania wodnych kompozycji trudnorozpuszczalnych w wodzie substancji czynnych | |
EP1946830A4 (en) | MICROREACTOR AND METHOD OF LIQUIDATION USING THEREOF | |
EP2098227A4 (en) | NON-CARIOUS MATERIAL AND ANTI-CARRY AGENT CONTAINING RARE SUGAR | |
PL2679220T3 (pl) | Tabletka typu pompy osmotycznej o kontrolowanej porowatości i sposób jej wytwarzania | |
IL212880A0 (en) | Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same | |
IL175605A0 (en) | Controlled release of topirimate in liquid dosage forms | |
TWI367761B (en) | Pharmaceutical composition containing hardly water soluble pharmaceutical substance | |
EP2104422A4 (en) | INHIBITION OF OSTWALD MATURATION IN CHEMICAL FORMULATIONS | |
ZA200708530B (en) | Pharmaceutical composition and method using antifungal agent in combination | |
SI2068891T1 (sl) | Sestavek, ki obsega gastrolitne komponente rakov, kalcijev karbonat, in njegova uporaba | |
EP1819323A4 (en) | PHARMACEUTICAL COMPOSITION WITH ANTI-SKIN COMPOSER | |
GB2430428B (en) | Device and method for the metering of solutions | |
PT2007347T (pt) | Composiçãocompreendendo um agente para estabilizar substâncias activas na água potável, mistura efervescente, método para a sua produção e seu uso | |
IL185970A0 (en) | Composition of spirulinas rich in active ingredients, method for obtaining it and its use | |
EP2020426A4 (en) | FOAM, COMPOSITION FOR FOAM AND USE OF FOAM | |
BRPI0722057A2 (pt) | Composto, prodroga, composição farmacêutica, método para prevenir ou tratar distúrbio do sono, e, uso do composto. | |
TWI346671B (en) | Chemical composition and process | |
ZA200805870B (en) | One-way valve and apparatus and method of using the valve | |
GB0617875D0 (en) | Controlled delivery creatine formulations and method of using the same |